Hims & Hers (NYSE: HIMS) legal chief sale leaves 313,964 shares

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that Chief Legal Officer Soleil Boughton sold 25,111 shares of Class A Common Stock on August 19, 2026 at $27.55 per share. The sales were effected under a Rule 10b5-1 trading plan adopted on May 21, 2026, and Boughton now directly holds 313,964 shares.

Insider Trade Summary 10b5-1

Net Seller: 25,111 shares

Net Sell 1 txn

Insider Boughton Soleil

Role Chief Legal Officer

Sold 25,111 shs ($692K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1	25,111	$27.55	$692K

Holdings After Transaction: Class A Common Stock — 313,964 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.

Key Figures

Shares sold: 25,111 shares Sale price per share: $27.55 per share Shares owned after transaction: 313,964 shares +1 more

4 metrics

Shares sold 25,111 shares Class A Common Stock sale on August 19, 2026

Sale price per share $27.55 per share Open market or private transaction on August 19, 2026

Shares owned after transaction 313,964 shares Direct ownership following August 19, 2026 sale

Rule 10b5-1 plan adoption date May 21, 2026 Adoption date of trading plan governing the reported sales

Key Terms

Rule 10b5-1 trading plan, Class A Common Stock, Reporting Person

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Reporting Person regulatory

"adopted on May 21, 2026 by the Reporting Person"

FAQ

What insider transaction did HIMS report for Soleil Boughton?

Hims & Hers Health, Inc. reported that Chief Legal Officer Soleil Boughton sold 25,111 shares of Class A Common Stock on August 19, 2026 at $27.55 per share, leaving her with 313,964 shares held directly.

Was the August 19, 2026 HIMS insider sale under a 10b5-1 plan?

Yes. The Form 4 states the sales on August 19, 2026 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the reporting person.

How many HIMS shares did Soleil Boughton sell and at what price?

Soleil Boughton sold 25,111 shares of Hims & Hers Health, Inc. Class A Common Stock at a price of $27.55 per share in a single reported transaction.

How many HIMS shares does Soleil Boughton own after the reported sale?

Following the August 19, 2026 sale, Soleil Boughton directly owns 313,964 shares of Hims & Hers Health, Inc. Class A Common Stock, as reported in the Form 4.

What role does the reporting person hold at Hims & Hers Health, Inc. (HIMS)?

The reporting person, Soleil Boughton, is identified as the Chief Legal Officer of Hims & Hers Health, Inc. in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 04:30 PM Accepted by SEC EDGAR 08/20/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/19/2026		S(1)		25,111	D	$27.55	313,964	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)